Ophthalmologica

Papers
(The H4-Index of Ophthalmologica is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration95
Age-Related Macular Degeneration: Pathophysiology, Management, and Future Perspectives68
Clinical Perspectives and Trends: Microperimetry as a Trial Endpoint in Retinal Disease34
New Insights in Resistant Diabetic Macular Edema22
Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment21
Incidence of Retinal Detachment in Germany: Results from the Gutenberg Health Study15
Evaluation of an Artificial Intelligence-Based Detector of Sub- and Intraretinal Fluid on a Large Set of Optical Coherence Tomography Volumes in Age-Related Macular Degeneration and Diabetic Macular E12
Complications Associated with Worse Visual Outcomes in Patients with Exudative Neovascular Age-Related Macular Degeneration12
Looking Ahead: Visual and Anatomical Endpoints in Future Trials of Diabetic Macular Ischemia12
Predictive Factors for Long-Term Postoperative Visual Outcome in Patients with Macula-Off Rhegmatogenous Retinal Detachment Treated with Vitrectomy10
Intravitreal Aflibercept versus Brolucizumab for Treatment-Naive Neovascular Age-Related Macular Degeneration with Type 1 Macular Neovascularization: Comparison of Short-Term Outcomes10
0.029542922973633